Zacks Investment Research upgraded shares of TerraVia Holdings Inc. (NASDAQ:TVIA) from a hold rating to a buy rating in a research report report published on Tuesday morning. They currently have $1.50 price objective on the stock.
According to Zacks, “TerraVia Holdings, Inc. provides food, nutrition and specialty ingredients. It offers algae-based food, nutrition and personal care ingredients. TerraVia Holdings, Inc., formerly known as Solazyme Inc., is headquartered in South San Francisco, California. “
Shares of TerraVia Holdings (NASDAQ:TVIA) opened at 1.70 on Tuesday. The company’s market capitalization is $153.35 million. The company has a 50 day moving average of $2.10 and a 200-day moving average of $2.40. TerraVia Holdings has a 12-month low of $1.18 and a 12-month high of $3.34.
TerraVia Holdings (NASDAQ:TVIA) last announced its quarterly earnings data on Wednesday, November 2nd. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.16) by $0.08. The firm had revenue of $4.31 million for the quarter, compared to the consensus estimate of $10.49 million. The firm’s revenue was down 4.6% on a year-over-year basis. On average, equities analysts anticipate that TerraVia Holdings will post ($0.99) EPS for the current fiscal year.
In other news, General Counsel Paul T. Quinlan sold 10,000 shares of the company’s stock in a transaction dated Friday, October 14th. The shares were sold at an average price of $2.55, for a total value of $25,500.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 9.90% of the stock is currently owned by insiders.
Several large investors have recently bought and sold shares of TVIA. KCG Holdings Inc. purchased a new stake in TerraVia Holdings during the third quarter valued at $109,000. BlackRock Advisors LLC raised its stake in TerraVia Holdings by 18.9% in the third quarter. BlackRock Advisors LLC now owns 43,497 shares of the company’s stock valued at $120,000 after buying an additional 6,906 shares during the last quarter. The Manufacturers Life Insurance Company purchased a new stake in TerraVia Holdings during the third quarter valued at $168,000. Ausdal Financial Partners Inc. raised its stake in TerraVia Holdings by 1.0% in the third quarter. Ausdal Financial Partners Inc. now owns 63,200 shares of the company’s stock valued at $174,000 after buying an additional 600 shares during the last quarter. Finally, Rockefeller Financial Services Inc. raised its stake in TerraVia Holdings by 107.4% in the third quarter. Rockefeller Financial Services Inc. now owns 70,274 shares of the company’s stock valued at $193,000 after buying an additional 36,392 shares during the last quarter. 35.26% of the stock is currently owned by institutional investors and hedge funds.
TerraVia Holdings Company Profile
Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.